Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 22.01B |
| Enterprise Value | 23.06B |
| P/E Ratio | 6.42 |
| PEG Ratio | 0.39 |
| Price/Sales Ratio | 9.12 |
| Price/Book Ratio | 0.59 |
| Enterprise/Revenue | 8.99 |
| Enterprise/EBITDA | 22.81 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 1.34 |
| Operating Margin | 1.3 |
| Return On Assets | 0.08 |
| Return On Equity | 0.09 |
| Revenue | 2.34B |
| Revenue/Share | 1.99 |
| Gross Profit | 1.06B |
| EBITDA | 49.59M |
| Net Income | 2.4B |
| Diluted EPS | 2.12 |
| Total Cash | 3.08B |
| Total Cash/Share | 2.74 |
| Total Debt | 1.08B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 1.73 |
| Book Value Per Share | 29.15 |
| 52-Week Change | -19.48 |
| 52-Week High | 21.47 |
| 52-Week Low | 16.36 |
| Moving Average 50 Days | 17.42 |
| Moving Average 200 Days | 17.96 |
| Average Volume | 10.24M |
| Shares Outstanding | 1.2B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 2.93 |
| Payout Ratio | 0.22 |
| Last Split Factor | 13:10 |
| Last Split Date | June 19, 2017 |